Transaction · 0000914190-26-000089
TECHBIO-TECHNE Corp
Bohnen Shane
Bohnen Shane, GC, reported a transaction classified as exercise at BIO-TECHNE Corp involving 8400.000000 shares for an estimated $399840.00. Reported holdings after the transaction were 14304.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
exerciseSEC transaction code MGC
- Trade date
- May 05, 2026
- Filing date
- May 07, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TECH price since this filing
Daily closing prices, with the filing date and available return windowsTECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -2.8%1w ago1d ago +0.0%
Returns since7d30d -7.7%90d +30.9%180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0000914190-26-000089 Common Stock
- Transaction date
- May 05, 2026 Filed May 07, 2026, 09:24 PM · 2d delay
- Shares
- 8,400 sh $47.60 per share
- Estimated value
- $399k Computed from shares × price
- Holdings after
- 14,304 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
Filing-only score
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
Positive filing signal
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
SVP - General Counsel
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
Fully exercisable.
- F2
Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024.
- F3
Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
- F4
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F5
Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
- F6
49 restricted stock units vest on 8/15/2026.
- F7
Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F8
Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F9
1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
- F10
Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- F11
Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F12
2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
- F13
Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028.
Related transactions
Same SEC filing0 other transactions
Recent company activity
TECH0 recent txs